DNA断裂におけるアロステリックPARP-1保持の構造的基礎
Levani Zandarashvili1, Marie-France Langelier2, Uday Kiran Velagapudi3
1Department of Biochemistry and Biophysics, Penn Center for Genome Integrity, Epigenetics Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
まとめ
ポリ ((ADP-リボース) ポリメラーゼ-1 (PARP-1) 阻害剤は,DNAの破裂時にPARP-1を捕まえる. 研究者はPARP-1を抑制する新しい阻害剤を開発し,がん細胞の殺戮を強化し,新しい臨床的選択肢を提供しました.
科学分野:
- 生物化学
- 分子生物学
- ガン治療薬
背景:
- ポリ (ADP-リボース) ポリメラーゼ-1 (PARP-1) 阻害剤 (PARPi) は,DNA破裂時にPARP-1を捕まえてがん治療に不可欠です.
- 既存のPARPiは,酵素の触媒センターを標的とするにもかかわらず,変動する捕獲効率を示しています.
研究 の 目的:
- 異なるPARPiがDNA破裂からPARP-1の保持または放出に影響を与えるアロステリックメカニズムを調査する.
- PARP-1アロステリーを調節することで,がん細胞の殺戮能力を強化した新しい PARPiを設計する.
主な方法:
- PARPiとPARP-1との様々な相互作用の構造分析
- PARP-1の放出と保持のダイナミクスを評価するアロステリック調節試験.
- 新しいPARPi化合物の開発と評価
主要な成果:
- 構造的に異なるPARPiは,DNA破裂時にPARP-1の放出または保持を促進するアロステリック変化を誘導することが判明しました.
- 新しく合成されたPARPiは,アロステリックプロリリース化合物をプロ保持剤に変換した.
- エンジニアリングによるプロレテンション PARPiは,がん細胞を殺す効果が向上したことを示した.
結論:
- PARP- 1アロステリーは,阻害剤の効能とDNA破裂トラッピングの決定的な決定因子です.
- PARP-1アロステリーをターゲットにすることで より効果的ながん治療薬の開発に 有望な戦略が生まれます
- PARP- 1の保持と放出を制御する能力は,PARPiの臨床応用に重要な意味を持つ.
関連する概念動画
Long-patch Base Excision Repair
7.7K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.7K
Restarting Stalled Replication Forks
6.2K
DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
6.2K
DNA Damage can Stall the Cell Cycle
9.9K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.9K
DNA Damage Can Stall the Cell Cycle
3.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.0K
Base Excision Repair
25.7K
One of the common DNA damages is the chemical alteration of single bases by alkylation, oxidation, or deamination. The altered bases cause mispairing and strand breakage during replication. This type of damage causes minimal change to the DNA double helix structure and can be repaired by the base excision repair (BER) pathways. BER corrects damaged DNA sequences by removing the damaged base and restoring the original base sequence using the complementary strand as a template.
The first step of...
The first step of...
25.7K
Base Excision Repair
4.9K
4.9K


